The epidemiological transition in Papua New Guinea: new evidence from verbal autopsy studies.


Journal

International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871

Informations de publication

Date de publication:
01 06 2019
Historique:
accepted: 26 02 2019
pubmed: 28 3 2019
medline: 2 4 2020
entrez: 28 3 2019
Statut: ppublish

Résumé

Recent economic growth in Papua New Guinea (PNG) would suggest that the country may be experiencing an epidemiological transition, characterized by a reduction in infectious diseases and a growing burden from non-communicable diseases (NCDs). However, data on cause-specific mortality in PNG are very sparse, and the extent of the transition within the country is poorly understood. Mortality surveillance was established in four small populations across PNG: West Hiri in Central Province, Asaro Valley in Eastern Highlands Province, Hides in Hela Province and Karkar Island in Madang Province. Verbal autopsies (VAs) were conducted on all deaths identified, and causes of death were assigned by SmartVA and classified into five broad disease categories: endemic NCDs; emerging NCDs; endemic infections; emerging infections; and injuries. Results from previous PNG VA studies, using different VA methods and spanning the years 1970 to 2001, are also presented here. A total of 868 deaths among adolescents and adults were identified and assigned a cause of death. NCDs made up the majority of all deaths (40.4%), with the endemic NCD of chronic respiratory disease responsible for the largest proportion of deaths (10.5%), followed by the emerging NCD of diabetes (6.2%). Emerging infectious diseases outnumbered endemic infectious diseases (11.9% versus 9.5%). The distribution of causes of death differed across the four sites, with emerging NCDs and emerging infections highest at the site that is most socioeconomically developed, West Hiri. Comparing the 1970-2001 VA series with the present study suggests a large decrease in endemic infections. Our results indicate immediate priorities for health service planning and for strengthening of vital registration systems, to more usefully serve the needs of health priority setting.

Sections du résumé

BACKGROUND
Recent economic growth in Papua New Guinea (PNG) would suggest that the country may be experiencing an epidemiological transition, characterized by a reduction in infectious diseases and a growing burden from non-communicable diseases (NCDs). However, data on cause-specific mortality in PNG are very sparse, and the extent of the transition within the country is poorly understood.
METHODS
Mortality surveillance was established in four small populations across PNG: West Hiri in Central Province, Asaro Valley in Eastern Highlands Province, Hides in Hela Province and Karkar Island in Madang Province. Verbal autopsies (VAs) were conducted on all deaths identified, and causes of death were assigned by SmartVA and classified into five broad disease categories: endemic NCDs; emerging NCDs; endemic infections; emerging infections; and injuries. Results from previous PNG VA studies, using different VA methods and spanning the years 1970 to 2001, are also presented here.
RESULTS
A total of 868 deaths among adolescents and adults were identified and assigned a cause of death. NCDs made up the majority of all deaths (40.4%), with the endemic NCD of chronic respiratory disease responsible for the largest proportion of deaths (10.5%), followed by the emerging NCD of diabetes (6.2%). Emerging infectious diseases outnumbered endemic infectious diseases (11.9% versus 9.5%). The distribution of causes of death differed across the four sites, with emerging NCDs and emerging infections highest at the site that is most socioeconomically developed, West Hiri. Comparing the 1970-2001 VA series with the present study suggests a large decrease in endemic infections.
CONCLUSIONS
Our results indicate immediate priorities for health service planning and for strengthening of vital registration systems, to more usefully serve the needs of health priority setting.

Identifiants

pubmed: 30915430
pii: 5420303
doi: 10.1093/ije/dyz018
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

966-977

Informations de copyright

© The Author(s) 2019; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Auteurs

Hebe N Gouda (HN)

School of Public Health, University of Queensland, Brisbane, QLD, Australia.

Riley H Hazard (RH)

University of Melbourne, School of Population and Global Health, Melbourne, VIC, Australia.

Seri Maraga (S)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Abraham D Flaxman (AD)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Andrea Stewart (A)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Jonathan C Joseph (JC)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Patricia Rarau (P)

University of Melbourne, School of Population and Global Health, Melbourne, VIC, Australia.
Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Regina Wangnapi (R)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Harry Poka (H)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Peter Serina (P)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Suparat Phuanukoonnon (S)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Bang N Pham (BN)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Miriam Vano (M)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Sebeya Lupiwa (S)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Albert Sie (A)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Helen Kave (H)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Deborah Lehmann (D)

Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.

Peter Siba (P)

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands, Papua New Guinea.

Alan D Lopez (AD)

University of Melbourne, School of Population and Global Health, Melbourne, VIC, Australia.

Ian D Riley (ID)

University of Melbourne, School of Population and Global Health, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH